Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 16, 2021

SELL
$7.04 - $11.7 $103,417 - $171,873
-14,690 Closed
0 $0
Q3 2020

Jun 26, 2023

BUY
$9.98 - $18.04 $146,606 - $265,007
14,690 New
14,690 $156,000
Q2 2020

May 24, 2024

BUY
$7.49 - $15.16 $110,028 - $222,700
14,690 New
14,690 $223 Million
Q2 2020

Jun 26, 2023

BUY
$7.49 - $15.16 $110,028 - $222,700
14,690 New
14,690 $222,000
Q2 2020

Mar 22, 2023

BUY
$7.49 - $15.16 $25,945 - $52,514
3,464 Added 30.86%
14,690 $222,000
Q2 2020

Aug 14, 2020

BUY
$7.49 - $15.16 $25,945 - $52,514
3,464 Added 30.86%
14,690 $223,000
Q1 2020

Jul 12, 2023

BUY
$4.62 - $18.74 $51,864 - $210,375
11,226 New
11,226 $93,000
Q4 2019

Jul 12, 2023

BUY
$14.6 - $18.13 $163,899 - $203,527
11,226 New
11,226 $189,000
Q3 2019

Jul 12, 2023

BUY
$16.62 - $23.92 $186,576 - $268,525
11,226 New
11,226 $208,000
Q3 2019

Mar 22, 2023

SELL
$16.62 - $23.92 $2,027 - $2,918
-122 Reduced 1.08%
11,226 $208,000
Q3 2019

Nov 14, 2019

SELL
$16.62 - $23.92 $2,027 - $2,918
-122 Reduced 1.08%
11,226 $208,000
Q2 2019

Jul 12, 2023

BUY
$17.79 - $22.88 $278,324 - $357,957
15,645 New
15,645 $357,000
Q1 2019

Jul 13, 2023

BUY
$11.76 - $22.15 $133,452 - $251,358
11,348 New
11,348 $238,000
Q4 2018

Jul 13, 2023

BUY
$10.42 - $21.94 $118,246 - $248,975
11,348 New
11,348 $130,000
Q4 2018

Mar 22, 2023

SELL
$10.42 - $21.94 $69,855 - $147,085
-6,704 Reduced 37.14%
11,348 $130,000
Q4 2018

Feb 14, 2019

SELL
$10.42 - $21.94 $69,855 - $147,085
-6,704 Reduced 37.14%
11,348 $131,000
Q3 2018

Jul 13, 2023

BUY
$20.4 - $24.6 $231,499 - $279,160
11,348 New
11,348 $260,000
Q3 2018

Mar 22, 2023

BUY
$20.4 - $24.6 $368,260 - $444,079
18,052 New
18,052 $414,000
Q3 2018

Nov 14, 2018

BUY
$20.4 - $24.6 $136,761 - $164,918
6,704 Added 59.08%
18,052 $414,000
Q4 2017

Feb 15, 2018

BUY
$18.0 - $30.0 $204,264 - $340,440
11,348
11,348 $297,000

Others Institutions Holding AXDX

About Accelerate Diagnostics, Inc


  • Ticker AXDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 99,059,904
  • Market Cap $191M
  • Description
  • Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious ...
More about AXDX
Track This Portfolio

Track Met Life Investment Management, LLC Portfolio

Follow Met Life Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.